The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.
At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.
Abogen Biosciences makes it on this list by virtue of an impressive $700 million series C round that it bagged in August 2021 – still one of the biggest ever private biotech funding rounds. This was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback